BIONOMICS LIMITED
BNO - Healthy Investment eConference - Dr Deborah Rathjen, CEO and Managing Director
Wednesday, 1 July 2009 11:00am
Select a tab above to display more information
BIONOMICS LIMITED (BNO)
ASX code: BNO
Website: http://www.bionomics.com.au/
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Principal Activities:
Developer of innovative treatments for cancer, mutiple sclerosis, anxiety and epilepsy.
Address:
, , 31 Dalgleish Street,
THEBARTON
SA
Phone: 08 8354 6100
Fax: 08 8354 6199
Executives & Directors
Mr Chris Fullerton , Chairman
Dr Deborah Rathjen , Managing Director, CEO
Dr Errol De Souza , Non Exec. Director
Mr Trevor Tappenden , Non Exec. Director
Mr Trevor Thiele , CFO
Mr Trevor Thiele , Company Secretary
Company Podcasts
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
BIONOMICS LIMITED (BNO) Events
BIONOMICS LIMITED (BNO)
| Bionomics NOW Newsletter March 2010 | Tue, 16 Mar 2010 |
| BNC210 Clinical Trial Results | Tue, 2 Mar 2010 |
| Half Yearly Report and Accounts | Thu, 18 Feb 2010 |
| Appendix 3B | Tue, 9 Feb 2010 |
| U.S. Investor Presentation | Tue, 9 Feb 2010 |
| Bionomics Limited Broadcast | Thu, 4 Feb 2010 |
| Positive New BNC210 Data | Tue, 2 Feb 2010 |
| Appendix 4C - quarterly | Thu, 28 Jan 2010 |
| BNC105 US Renal Cancer Trial Initiated | Wed, 27 Jan 2010 |
| Appendix 3B | Thu, 21 Jan 2010 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.




















